Furthermore, although no binding activity was observed between HMGB1 and GlucoGL, which binds strongly to PGRMC1, GlucoGL exhibited a more potent anti-cancer effect in vitro and in vivo (Figure 6). This evidence concerns the gene HMGB1 and cancer.